Green LifeScience Co

Green LifeScience Co ROE

The Return on Equity (ROE) of Green LifeScience Co (114450.KQ) as of Oct 25, 2026 is 0.29 %. In the previous year, Return on Equity (ROE) was 4.37 % — a change of -93.42% (lower).

ROE

0.29 %

YoY

-93.42%

Last updated:

In 2025, Green LifeScience Co's return on equity (ROE) was 0.29 %, a -93.42% increase from the 4.37 % ROE in the previous year.

The Green LifeScience Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
-2.45 KRW
Jan 1, 2019
1.98 KRW
Jan 1, 2020
-1.78 KRW
Jan 1, 2021
-5.57 KRW
Jan 1, 2022
-6.70 KRW
Jan 1, 2023
-45.50 KRW
Jan 1, 2024
4.37 KRW
Jan 1, 2025
0.29 KRW
The Green LifeScience Co ROE history
YEARROEYoY
0.29 %-93.42%
4.37 %-109.60%
-45.50 %+579.29%
-6.70 %+20.24%
-5.57 %+212.13%
-1.78 %-190.08%
1.98 %-181.02%
-2.45 %-168.24%
3.58 %-50.95%
7.30 %-22.84%
9.47 %-559.51%
-2.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Green LifeScience Co Stock analysis

What does Green LifeScience Co do? Green LifeScience Co Ltd produces and sells pharmaceutical and agricultural raw materials and intermediates, including AMZ for crop protection, TAZD as a herbicide intermediate, D003M and T003M for artificial marble additives, and PM04 as a pharmaceutical intermediate. The company distributes its products domestically and to international markets such as Japan, the United States, and Europe, where customers purchase these materials for agricultural and pharmaceutical applications. The firm also offers antibiotics as part of its product portfolio, targeting both domestic and overseas buyers seeking specialized chemical compounds. Green LifeScience Co Ltd generates revenue through the sale of its chemical products to customers in the agricultural and pharmaceutical sectors, with key markets including Japan, the United States, and European countries. The company’s product line caters to the needs of manufacturers requiring raw materials for crop protection, herbicides, and pharmaceutical production. Its domestic and international distribution channels support consistent sales across these segments, leveraging established relationships with buyers in the chemical supply chain. The company's offerings include specific chemical compounds like AMZ, TAZD, D003M, T003M, and PM04, which are sold to customers who integrate them into larger production processes. These products are used in the creation of crop protection materials, herbicides, artificial marble, and pharmaceuticals, serving both local and global markets. Antibiotics are also part of the sales mix, contributing to the firm’s revenue from chemical intermediates and raw materials. Green LifeScience Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding Green LifeScience Co's Return on Equity (ROE)

Green LifeScience Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Green LifeScience Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Green LifeScience Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Green LifeScience Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Green LifeScience Co stock

Return on Equity (ROE) of Green LifeScience Co is 0.29 % in 2025.

Return on Equity (ROE) of Green LifeScience Co changed from 4.37 % to 0.29 %, representing a -93.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Green LifeScience Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Green LifeScience Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Green LifeScience Co

All Key Metrics — Green LifeScience Co